News & Insights

Stay Informed With Our Latest Updates

Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.

Insights > Keyword
Insights > Type
Global > Practices
Global > Industries
Insights > Location
Insights > Person
Insights > Date Filter
3630 Results Found

Firm News December 3, 2025

Gibson Dunn Represented Mauser Packaging Solutions on $3.9 Billion Notes Exchange, $1 Billion Term Loan Financing, ABL Credit Facility Maturity Extension, and Cash Flow Revolver Maturity Extension

Gibson Dunn represented Mauser Packaging Solutions in an exchange offer of $2.6 billion in aggregate principal amount of their outstanding 7.875% Senior First Lien Notes due 2027 for newly issued 7.875% Senior First Lien Notes due 2030 and $1.3 billion in aggregate principal amount of their outstanding 9.25% Senior Secured Second Lien Notes due 2027 for newly issued 9.25% Senior Secured Second Lien Notes due 2030.

Firm News November 7, 2025

Gibson Dunn Advised Platinum Equity and Solenis on Acquisition of NCH

Gibson Dunn advised Platinum Equity and Solenis on the acquisition of NCH Corporation, an expert in middle-market water treatment and industrial solutions

Firm News October 28, 2025

Gibson Dunn Advised BVP Forge on Investment in Strategic Combination of Sunwave Health and Lightning Step

Gibson Dunn advised BVP Forge on its investment in the strategic combination of Sunwave Health and Lightning Step to form a unified technology platform, purpose-built for behavioral health providers nationwide

Firm News October 8, 2025

Gibson Dunn Represents Platinum Equity in Acquisition of Owens & Minor’s Products & Healthcare Services Segment

Gibson Dunn is representing Platinum Equity in its acquisition of the Products & Healthcare Services segment of Owens & Minor.

Firm News September 19, 2025

Gibson Dunn Advises 89bio on Its up to $3.5 Billion Sale to Roche Holdings

Gibson Dunn is advising 89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, on its up to $3.5 billion sale to Roche Holdings, Inc.

Firm News August 20, 2025

Gibson Dunn Advises Certain Senior Creditors in Recapitalization of Mavenir Systems

Gibson Dunn advised affiliated lenders and noteholders of a special situations fund in connection with the comprehensive recapitalization of Mavenir Systems, Inc., a cloud-native network infrastructure provider

Firm News July 31, 2025

Gibson Dunn Represented Aurora Capital Partners and FMG Suite on the Sale of FMG Suite to GTCR

Gibson Dunn represented Aurora Capital Partners and FMG Suite on the sale of FMG Suite to GTCR.

Firm News July 23, 2025

Gibson Dunn is Representing Polymarket in Its $112 Million Acquisition of QCEX

Gibson Dunn is representing Polymarket, the world's largest prediction market, in its acquisition of QCEX, a CFTC-regulated exchange and clearinghouse.